Spots Global Cancer Trial Database for CryoSpray Ablation (TM) GI Patient Registry
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: CryoSpray Ablation (TM) GI Patient Registry
Official Title: CryoSpray Ablation (TM) GI Patient Registry
Study ID: NCT00747448
Interventions
Study Description
Brief Summary: The purpose of this study is to create a patient registry to collect and analyze post-510K approval information on subjects treated endoscopically with the CryoSpray Ablation™ System.
Detailed Description: The proposed registry is a prospective, multi-center study of patients that are being currently undergoing CryoSpray Ablation™. It will also be used to catalogue retrospective data from records of patients already treated with the device. A maximum of 40 investigational sites will participate in this study.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
The Scripps Research Institute, LaJolla, California, United States
University of Maryland Medical Center, Baltimore, Maryland, United States
Syosset Hospital, Lake Success, New York, United States
University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, United States
Cleveland Clinic Foundation, Cleveland, Ohio, United States
Rhode Island Hospital, Providence, Rhode Island, United States
Contact Details
Name: Ann Murphy Legg, RN
Affiliation: CSA Medical, Inc.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
